Editorial: Challenges in developing new multiple sclerosis therapies di Michael K. Racke

Testo

Natalizumab: increased vigilance is required in treating patients with multiple sclerosis di Michael K. Racke, Olaf Stüve

Testo

PPARs in Neuroinflammation di Paul D. Drew, Michael K. Racke

Testo

Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes di Michael K. Racke, Elliot M. Frohman, Teresa Frohman

Testo

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs di Yuhong Yang, Amy E. Lovett-Racke, Michael K. Racke

Testo

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis di Michael K. Racke, Paul D. Drew, Amy Lovett-Racke, Yuhong Yang, Anne R. Gocke

Testo

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients. di Karen Yao, Susan Gagnon, Nahid Akhyani, Elizabeth Williams, Julie Fotheringham, Elliot Frohman, Olaf Stuve, Nancy Monson, Michael K Racke, Steven Jacobson

Testo

PEG minocycline-liposomes ameliorate CNS autoimmune disease. di Wei Hu, Josbert Metselaar, Li-Hong Ben, Petra D Cravens, Mahendra P Singh, Elliot M Frohman, Todd N Eagar, Michael K Racke, Bernd C Kieseier, Olaf Stüve

Testo

A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance di Saba I. Aqel, Xiaozhi Yang, Emma E. Kraus, Jinhua Song, Marissa F. Farinas, Erin Y. Zhao, Wei Pei, Amy E. Lovett-Racke, Michael K. Racke, Chenglong Li, Yuhong Yang

Testo

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. di Nancy L Monson, Petra Cravens, Rehana Hussain, Christopher T Harp, Matthew Cummings, Maria de Pilar Martin, Li-Hong Ben, Julie Do, Jeri-Anne Lyons, Amy Lovette-Racke, Anne H Cross, Michael K Racke, Olaf Stüve, Mark Shlomchik, Todd N Eagar

Testo

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment di Darren M. Weber, Steven W. Taylor, Robert J. Lagier, Jueun C. Kim, Scott M. Goldman, Nigel J. Clarke, David E. Vaillancourt, Ranjan Duara, Ranjan Duara, Karen N. McFarland, Wei-en Wang, Todd E. Golde, Todd E. Golde, Michael K. Racke

Testo

K27-linked RORγt ubiquitination by Nedd4 potentiates Th17-mediated autoimmunity di Qiuming Zeng, Hui Guo, Na Tang, Pranav S. Renavikar, Nitin J. Karandikar, Amy E. Lovett-Racke, Michael K. Racke, Chengkai Yan, Rong Tang, Sushmita Sinha, Krishnendu Ghosh, Jeremy P. Ryal, Song Ouyang, Min Chen, Foued Amari, Coppola Vincenzo, R. Marshall Pope, Yalan Li, Huan Yang, Wallace Y. Langdon, Jian Zhang

Testo

A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple scler... di Elliot M. Frohman, Gary Cutter, Gina Remington, Hongjiang Gao, Howard Rossman, Bianca Weinstock-Guttman, Jacqueline E. Durfee, Amy Conger, Ellen Carl, Katherine Treadaway, Eric Lindzen, Amber Salter, Teresa C. Frohman, Anjali Shah, Angela Bates, Jennifer L. Cox, Michael G. Dwyer, Olaf Stuve, Benjamin M. Greenberg, Michael K. Racke, Robert Zivadinov

Testo

Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination di Hiromitsu Asashima, Dongjoo Kim, Kaicheng Wang, Nikhil Lele, Nicholas C. Buitrago-Pocasangre, Rachel Lutz, Isabella Cruz, Khadir Raddassi, William E. Ruff, Michael K. Racke, JoDell E. Wilson, Tara S. Givens, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Steven H. Kleinstein, Ruth R. Montgomery, Albert C. Shaw, Fangyong Li, Rong Fan, David A. Hafler, Mary M. Tomayko, Erin E. Longbrake

Testo